Ventegra Partners with Scipher Medicine For Patient-Centric Approach To Improve Outcomes and Lower Costs for Rheumatoid Arthritis Care
16 sept. 2021 08h00 HE
|
Scipher Medicine Corporation
WALTHAM, Mass., Sept. 16, 2021 (GLOBE NEWSWIRE) -- Scipher Medicine, a precision immunology company matching patients with their most effective therapy, today announced a partnership with Ventegra,...
Scipher Medicine® and Ambry Genetics® Partner to Bring Precision Medicine Test for Rheumatoid Arthritis to Market
17 sept. 2020 08h00 HE
|
Scipher Medicine Corporation
PrismRA® first-of-its-kind molecular signature test validated in Ambry’s central laboratory.Partnership provides infrastructure for rapid scaling and patient accessibility. WALTHAM, Mass. and...